Integrins as Therapeutic Targets for SARS-CoV-2.

Autor: Gressett TE; Tulane University School of Medicine, Clinical Neuroscience Research Center (CNRC), New Orleans, LA, United States.; Department of Neurology, Tulane University School of Medicine, New Orleans, LA, United States.; Tulane Brain Institute, Tulane University, New Orleans, LA, United States., Nader D; RCSI University of Medicine and Health Sciences, School of Pharmacy and Biomolecular Sciences (PBS), Dublin, Ireland., Robles JP; Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Juriquilla, Mexico., Buranda T; University of New Mexico Health Sciences Center (HSC), Department of Pathology, Albuquerque, NM, United States., Kerrigan SW; RCSI University of Medicine and Health Sciences, School of Pharmacy and Biomolecular Sciences (PBS), Dublin, Ireland., Bix G; Tulane University School of Medicine, Clinical Neuroscience Research Center (CNRC), New Orleans, LA, United States.; Department of Neurology, Tulane University School of Medicine, New Orleans, LA, United States.; Tulane Brain Institute, Tulane University, New Orleans, LA, United States.
Jazyk: angličtina
Zdroj: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2022 Apr 29; Vol. 12, pp. 892323. Date of Electronic Publication: 2022 Apr 29 (Print Publication: 2022).
DOI: 10.3389/fcimb.2022.892323
Abstrakt: Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Databáze: MEDLINE